Reuters logo
BRIEF-Active Biotech Announce Results In Arpeggio Phase II Trial With Laquinimod In Primary Progressive MS
December 1, 2017 / 12:10 PM / 16 days ago

BRIEF-Active Biotech Announce Results In Arpeggio Phase II Trial With Laquinimod In Primary Progressive MS

Dec 1 (Reuters) - Active Biotech AB:

* ACTIVE BIOTECH ANNOUNCE RESULTS IN ARPEGGIO PHASE II TRIAL WITH LAQUINIMOD IN PRIMARY PROGRESSIVE MS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below